<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">CEN Case Rep</journal-id><journal-id journal-id-type="iso-abbrev">CEN Case Rep</journal-id><journal-title-group><journal-title>CEN Case Reports</journal-title></journal-title-group><issn pub-type="epub">2192-4449</issn><publisher><publisher-name>Springer Nature Singapore</publisher-name><publisher-loc>Singapore</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38825653</article-id><article-id pub-id-type="pmc">PMC11785861</article-id>
<article-id pub-id-type="publisher-id">894</article-id><article-id pub-id-type="doi">10.1007/s13730-024-00894-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Peritoneal dialysis-associated peritonitis, caused by superior mesenteric artery thrombosis with intestinal necrosis: a case report</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Osaki</surname><given-names>Yosuke</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Maeoka</surname><given-names>Yujiro</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Sami</surname><given-names>Mai</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Takahashi</surname><given-names>Akira</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Ishiuchi</surname><given-names>Naoki</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Sasaki</surname><given-names>Kensuke</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4271-9964</contrib-id><name><surname>Masaki</surname><given-names>Takao</given-names></name><address><email>masakit@hiroshima-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/038dg9e86</institution-id><institution-id institution-id-type="GRID">grid.470097.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0618 7953</institution-id><institution>Department of Nephrology, </institution><institution>Hiroshima University Hospital, </institution></institution-wrap>1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551 Japan </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>2</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>14</volume><issue>1</issue><fpage>1</fpage><lpage>5</lpage><history><date date-type="received"><day>26</day><month>11</month><year>2023</year></date><date date-type="accepted"><day>14</day><month>5</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Peritoneal dialysis (PD)-associated peritonitis is a common complication of PD. Enteric peritonitis is defined as peritonitis arising from an intestinal or intra-abdominal organ source. The delay in the diagnosis or treatment of enteric peritonitis has been reported to increase mortality. Therefore, the early consideration of enteric peritonitis, particularly in cases of culture-negative peritonitis, is imperative. A 67-year-old Japanese man who had been undergoing PD for 3&#x000a0;years, was admitted to our hospital with a diagnosis of PD-associated peritonitis. A month previously, he experienced a bleeding gastric ulcer, which led to severe anemia (hemoglobin 6.3&#x000a0;mg/dL), followed by thrombocytosis. On admission, peritoneal fluid analysis showed a high white blood cell count (WBC: 8,570 /&#x000b5;L), with neutrophils predominating (74.5%). Cultures of both his dialysis effluent and blood were negative. After admission, the WBC count of the dialysis effluent gradually decreased alongside antibiotic therapy, but the patient&#x02019;s abdominal pain did not improve. After 4&#x000a0;days, enhanced computed tomography showed superior mesenteric artery (SMA) thrombosis and intestinal necrosis. Therefore, emergency intestinal resection and PD catheter removal were performed, and then antithrombosis therapy was initiated. Because the patient&#x02019;s abdominal pain was improved and platelet count and <sc>d</sc>-dimer concentration were reduced by these treatments, he was discharged from the hospital after 47&#x000a0;days. Thus, we report a rare case of culture-negative PD-associated peritonitis, which was caused by SMA thrombosis and intestinal necrosis. It is likely that combination of severe calcification of SMA and prolonged thrombocytosis secondary to the severe anemia contributed to the thrombosis.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>PD-associated peritonitis</kwd><kwd>Enteric peritonitis</kwd><kwd>Superior mesothelial artery thrombosis</kwd></kwd-group><funding-group><award-group><funding-source><institution>Hiroshima University</institution></funding-source></award-group><open-access><p>Open Access funding provided by Hiroshima University.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Japanese Society of Nephrology 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Peritoneal dialysis (PD)-associated peritonitis is a common complication of PD and is associated with higher healthcare costs and mortality [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. The appropriate treatment for PD-associated peritonitis relies on the identification of the causative organisms in the peritoneal dialysis effluent [<xref ref-type="bibr" rid="CR4">4</xref>]. Therefore, the International Society for Peritoneal Dialysis (ISPD) guidelines of 2022 recommend reducing the proportion of culture-negative cases to&#x02009;&#x0003c;&#x02009;15%. However, large variations in the culture-negative proportion (13.4&#x02013;40%) have been reported [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. Therefore, more careful investigation is required to identify the causes of culture-negative peritonitis to choose the appropriate treatment.</p><p id="Par3">Enteric peritonitis, one of the established categories of PD-associated peritonitis, is defined as peritonitis arising from an intestinal or intra-abdominal organ source, and recognized as one of the conditions that should be considered in the case of culture-negative peritonitis [<xref ref-type="bibr" rid="CR8">8</xref>]. PD-associated peritonitis owing to some severe diseases, such as pancreatitis, appendicitis, and thrombosis, is included in this category [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>]. Furthermore, a delay in the diagnosis or treatment of enteric peritonitis has been reported to increase the associated mortality rate by approximately 50% [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Thrombosis is one of the key causes of enteric peritonitis, because patients who had decreased kidney function are at a high risk of thromboembolic events [<xref ref-type="bibr" rid="CR14">14</xref>]. Among the thrombotic diseases, superior mesothelial artery (SMA) thrombosis is difficult to diagnose and represents a serious emergency, with a reported mortality rate ranging from 40 to 80% [<xref ref-type="bibr" rid="CR15">15</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par4">Thrombocytosis is one of the major causes of the morbidity and mortality associated with thromboembolism [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Based on its etiology, thrombocytosis can be divided into two categories: primary thrombocytosis, such as essential thrombocytosis; and secondary thrombocytosis, caused by factors including malignant tumors, inflammation, hemorrhage, and medications [<xref ref-type="bibr" rid="CR21">21</xref>]. Furthermore, it has been established that primary thrombocytosis increases the risk of thrombosis [<xref ref-type="bibr" rid="CR20">20</xref>]. However, although secondary thrombocytosis rarely triggers thrombosis, some serious thrombotic diseases, such as abdominal aortic thrombosis and stroke, have been reported to cause secondary thrombocytosis [<xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par5">Here, we report a rare case of culture-negative PD-associated peritonitis, which was classified as enteric peritonitis, and caused by SMA thrombosis with intestinal necrosis.</p></sec><sec id="Sec2"><title>Case presentation</title><sec id="Sec3"><title>Clinical history</title><p id="Par6">A 67-year-old Japanese man who had been undergoing PD for 3&#x000a0;years presented to our hospital with abdominal pain of&#x02009;&#x0003e;&#x02009;1&#x000a0;week&#x02019;s duration and a cloudy peritoneal dialysate effluent. He had a history of exit-site and tunnel infection caused by <italic>Streptococcus agalactiae</italic>, and had undergone antibiotic treatment with cefepime and cefazolin and subcutaneous pathway diversion 2&#x000a0;months previously. In addition, he had undergone endoscopic hemostasis and a blood transfusion, owing to severe anemia (hemoglobin concentration 6.2&#x000a0;mg/dL) caused by a bleeding gastric ulcer, 1&#x000a0;month previously. To treat the anemia, ferrous citrate 100&#x000a0;mg/day was administered following the bleeding event, in addition to ferric citrate hydrate 2250&#x000a0;mg/day and darbepoetin 120&#x000a0;&#x000b5;g/month.</p></sec><sec id="Sec4"><title>Clinical course</title><p id="Par7">On admission, the patient was 158&#x000a0;cm tall, he weighed 68.5&#x000a0;kg, his body temperature was 36.9&#x000a0;&#x000b0;C, and his blood pressure was 98/62&#x000a0;mmHg. Physical examination revealed abdominal tenderness and swelling, but there were no findings suggestive of the recurrence of the exit site and tunnel infection. Electrocardiography revealed a heart rate of 67/min and sinus rhythm, without any abnormalities. He also had a high white blood cell (WBC) count, a high C-reactive protein (CRP) concentration, mild anemia, and thrombocytosis. Peritoneal fluid analysis showed a high WBC count (8570/&#x000b5;L), with neutrophils predominating (74.5%). Cultures of both the dialysis effluent and blood were negative (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Plain computed tomography (CT) showed a large amount of intra-abdominal adipose tissue, a typical finding of PD-associated peritonitis, but no findings consistent with a recurrence of the gastric ulcer hemorrhage. On the basis of these findings, we diagnosed PD-associated peritonitis.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Laboratory results on admission</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameter</th><th align="left">Value</th><th align="left">(Normal range)</th></tr></thead><tbody><tr><td align="left" colspan="3">(Blood)</td></tr><tr><td align="left">&#x000a0;Neutrophil</td><td align="left">89.5</td><td align="left">(38.3&#x02013;71.1)</td></tr><tr><td align="left">&#x000a0;Lymphocyte (%)</td><td align="left">5.5</td><td align="left">(21.3&#x02013;50.3)</td></tr><tr><td align="left">&#x000a0;Monocyte (%)</td><td align="left">4.8</td><td align="left">(2.7&#x02013;7.6)</td></tr><tr><td align="left">&#x000a0;Red blood cell (104/&#x003bc;L)</td><td align="left">334</td><td align="left">(378&#x02013;499)</td></tr><tr><td align="left">&#x000a0;Hemoglobin (g/dL)</td><td align="left">10</td><td align="left">(10.8&#x02013;14.9)</td></tr><tr><td align="left">&#x000a0;Hematocrit (%)</td><td align="left">30</td><td align="left">(35.6&#x02013;45.4)</td></tr><tr><td align="left">&#x000a0;Platelet (104/&#x003bc;L)</td><td align="left">72</td><td align="left">(15.0&#x02013;36.0)</td></tr><tr><td align="left">&#x000a0;Aspartate transaminase (U/L)</td><td align="left">23</td><td align="left">(13&#x02013;33)</td></tr><tr><td align="left">&#x000a0;Alanine transaminase (U/L)</td><td align="left">30</td><td align="left">(8&#x02013;42)</td></tr><tr><td align="left">&#x000a0;Lactate dehydrogenase (U/L)</td><td align="left">173</td><td align="left">(124&#x02013;222)</td></tr><tr><td align="left">&#x000a0;Alkaline phosphatase (U/L)</td><td align="left">92</td><td align="left">(38&#x02013;113)</td></tr><tr><td align="left">&#x000a0;&#x003b3;-Glutamyltransferase (U/L)</td><td align="left">8</td><td align="left">(13&#x02013;64)</td></tr><tr><td align="left">&#x000a0;Total bilirubin (mg/dL)</td><td align="left">0.2</td><td align="left">(0.4&#x02013;1.5)</td></tr><tr><td align="left">&#x000a0;Serum albumin (g/dL)</td><td align="left">1.1</td><td align="left">(4.0&#x02013;5.0)</td></tr><tr><td align="left">&#x000a0;Blood urea nitrogen (mg/dL)</td><td align="left">64.6</td><td align="left">(8&#x02013;20)</td></tr><tr><td align="left">&#x000a0;Creatinine (mg/dL)</td><td align="left">9.45</td><td align="left">(040&#x02013;0.70)</td></tr><tr><td align="left">&#x000a0;Na (mmol/L)</td><td align="left">133</td><td align="left">(138&#x02013;146)</td></tr><tr><td align="left">&#x000a0;K (mmol/L)</td><td align="left">3.4</td><td align="left">(3.6&#x02013;4.9)</td></tr><tr><td align="left">&#x000a0;Cl (mmol/L)</td><td align="left">96</td><td align="left">(99&#x02013;109)</td></tr><tr><td align="left">&#x000a0;Calcium (mg/dL)</td><td align="left">9.8</td><td align="left">(8.6&#x02013;10.4)</td></tr><tr><td align="left">&#x000a0;Phosphate (mg/dL)</td><td align="left">4.6</td><td align="left">(2.5&#x02013;4.7)</td></tr><tr><td align="left">&#x000a0;Uric acid (mg/dL)</td><td align="left">3.9</td><td align="left">(2.3&#x02013;7.0)</td></tr><tr><td align="left">&#x000a0;Fe (&#x000b5;g/dL)</td><td align="left">81</td><td align="left">(40&#x02013;188)</td></tr><tr><td align="left">&#x000a0;UIBC (&#x000b5;g/dL)</td><td align="left">13</td><td align="left">(112&#x02013;330)</td></tr><tr><td align="left">&#x000a0;Ferritin (ng/mL)</td><td align="left">676.3</td><td align="left">(35.1&#x02013;353.1)</td></tr><tr><td align="left">&#x000a0;C-reactive protein (mg/dL)</td><td align="left">6.27</td><td align="left">(&#x0003c;&#x02009;0.20)</td></tr><tr><td align="left" colspan="3">(Peritoneal dialysis effluent)</td></tr><tr><td align="left">&#x000a0;White-cell count (/&#x003bc;L)</td><td align="left">8.570</td><td align="left">Negative</td></tr><tr><td align="left">&#x000a0;Neutrophil (%)</td><td align="left">74.5</td><td align="left">Negative</td></tr><tr><td align="left">&#x000a0;Eosinophil (%)</td><td align="left">0.2</td><td align="left">Negative</td></tr><tr><td align="left" colspan="3">(Culture)</td></tr><tr><td align="left">&#x000a0;Bacterial culture (PD effluent)</td><td align="left">Negative</td><td align="left">Negative</td></tr><tr><td align="left">&#x000a0;Mycobacterium culture (PD effluent)</td><td align="left">No data</td><td align="left">Negative</td></tr><tr><td align="left">&#x000a0;Blood</td><td align="left">Negative</td><td align="left">Negative</td></tr></tbody></table></table-wrap></p><p id="Par8">We administered 0.5&#x000a0;mg/day of meropenem (MPEM) and 1.0&#x000a0;mg of vancomycin (VCM) intravenously to treat the PD-associated peritonitis (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>), and the cell counts in the dialysis effluent gradually decreased alongside the antibiotic treatment but there was no amelioration of the patient&#x02019;s abdominal pain. After 4&#x000a0;days of administration, laboratory testing revealed a high WBC count (25,370/&#x000b5;L) and a high D-dimer concentration (7.5&#x000a0;&#x000b5;g/dL). To differentiate PD-associated peritonitis from other diseases and evaluate the effectiveness of treatment, we performed contrast-enhanced CT. Abdominal CT revealed severe calcification of SMA, SMA thrombosis and intestinal necrosis, but no findings indicative of intestinal perforation (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Therefore, intestinal resection, ostomy, and PD catheter removal were performed on the same day. After this surgery, hemodialysis was initiated as a renal replacement therapy, 5000&#x000a0;U/day of heparin was administered as an antithrombotic treatment for 2&#x000a0;weeks, and then this was changed to oral warfarin administration. These treatments ameliorated the patient&#x02019;s abdominal pain and reduced his platelet count and <sc>d</sc>-dimer concentration. Because transesophageal echocardiography revealed no obvious cardiac abnormalities, he was discharged from hospital after 47&#x000a0;days.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>The clinical course of the patient. Changes in the cell counts in the dialysis effluent (orange lines), the white blood cell count (WBC, yellow lines), and the platelet count (PLT, blue lines). MEPM: meropenem, VCM: vancomycin</p></caption><graphic xlink:href="13730_2024_894_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Enhanced computed tomography (CT) findings. Enhanced CT revealed thrombosis of the superior mesenteric artery (SMA) (<bold>A</bold>), calcification of origin of SMA (<bold>B</bold>) and intestinal necrosis (<bold>C</bold>)</p></caption><graphic xlink:href="13730_2024_894_Fig2_HTML" id="MO2"/></fig></p></sec></sec><sec id="Sec5"><title>Discussion</title><p id="Par9">In this report, we have described a rare case of culture-negative PD-associated peritonitis caused by SMA thrombosis with intestinal necrosis, which was classified as enteric peritonitis. In addition, the combination of severe calcification of SMA and thrombocytosis secondary to the severe anemia triggered by the patient&#x02019;s bleeding gastric ulcer was considered to be the cause of his thrombosis.</p><p id="Par10">The identification of the causative organism in the dialysis effluent is important for the selection of the most appropriate treatment, and the identification of the underlying primary disease is required in culture-negative cases. In an attempt to identify the causative organism, we repeated the cultures of the patient&#x02019;s dialysis effluent and blood but we could not detect any bacteria. The most common explanations for culture-negative peritonitis are antibiotic therapy within the preceding 30&#x000a0;days and technical problems during the dialysate culture [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. The present patient had taken antibiotics to treat his exit-site and tunnel infection, but these had been administered 2&#x000a0;months previously, and, therefore, were not considered to be the cause of the negative culture result. It has been previously reported that culture-negative peritonitis is not associated with higher risks of hospitalization, death, or a change to hemodialysis [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. However, a delay in the diagnosis or treatment of enteric peritonitis, which is one of the conditions that should be considered in the case of culture-negative peritonitis, has been reported to increase mortality by approximately 50% [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Therefore, it is important to evaluate the reasons for culture negativity at an early stage, especially if treatment is ineffective [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR27">27</xref>].</p><p id="Par11">For the evaluation of the effectiveness of treatment, the WBC count of the dialysis effluent and the clinical symptoms should be evaluated longitudinally. Appropriate antibiotic treatment generally ameliorates the symptoms of patients within 72&#x000a0;h, but a WBC count in the dialysis effluent of&#x02009;&#x0003e;&#x02009;1090/&#x000b5;L 2&#x000a0;days following the initiation of treatment is a prognostic marker of treatment failure [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. The present patient was initially treated empirically with antibiotics, and his dialysis effluent WBC count slowly decreased with antimicrobial therapy and peritoneal lavage, but remained&#x02009;&#x0003e;&#x02009;2000/&#x000b5;L 4&#x000a0;days after the initiation of treatment. Moreover, his abdominal pain had not been ameliorated. In cases of inadequate response to antimicrobial treatment, eosinophilic peritonitis should be considered [<xref ref-type="bibr" rid="CR30">30</xref>]. In this case, we ruled out the eosinophilic peritonitis because there was no increase of eosinophils in PD effluent throughout the clinical course. This clinical course and the findings of enhanced CT confirmed that the antibiotic treatment had not been effective and that the PD-associated peritonitis was non-infectious and associated with SMA thrombosis and ischemic enteritis. In addition to CT imaging, the findings of PD effluent may be helpful in the early diagnosis of enteric peritonitis. It is reported that amylase concentrations is increased in PD effluent from enteric peritonitis including ischemic enteritis [<xref ref-type="bibr" rid="CR31">31</xref>]. Although we did not measure the amylase concentrations in PD effluent in this case, the measurement should be considered in suspected cases of enteric peritonitis.</p><p id="Par12">We investigated which underlying diseases might have contributed to the SMA thrombosis. Initially, we considered cardiac diseases, including intracardiac thrombi, acute myocardial infarction, and atrial fibrillation, as causes of the thrombosis, because cardiac diseases are reported to be a cause of 70% of cases of SMA thrombosis [<xref ref-type="bibr" rid="CR18">18</xref>]. However, the present patient did not have arrhythmia or a cardiac disease that could have caused his thrombosis. On the other hand, the CT revealed severe calcification of the SMA, which is reported as a cause of SMA thromboembolism [<xref ref-type="bibr" rid="CR32">32</xref>]. We considered that the stenosis of SMA contributed to thrombus formation. Additionally, laboratory testing on admission revealed thrombocytosis, which is also known to be associated with thromboembolism [<xref ref-type="bibr" rid="CR33">33</xref>]. Most cases of thrombosis caused by thrombocytosis are primary thrombosis, although severe thrombosis arising as a result of secondary thrombocytosis has also been documented [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. In the present case, a relationship between the thrombocytosis and hemorrhage was suspected, because the patient&#x02019;s platelet count increased from 29.5 to 72.0&#x02009;&#x000d7;&#x02009;10<sup>4</sup>/&#x000b5;L over the course of the month following the bleeding gastric ulcer. Therefore, we concluded that the combination of severe SMA calcification and secondary thrombocytosis played a role in the development of the SMA thrombosis.</p><p id="Par13">To investigate the cause of secondary thrombocytosis in detail, we assessed the patient&#x02019;s level of iron deficiency, which is known to be a contributing factor to secondary thrombocytosis [<xref ref-type="bibr" rid="CR35">35</xref>]. Song et al<italic>.</italic> reported that the risk of thrombosis is twice as high in patients with thrombocytosis and iron deficiency anemia than in those with iron deficiency anemia alone (15.8% <italic>vs</italic>. 7.8%, respectively) [<xref ref-type="bibr" rid="CR36">36</xref>]. On admission, the present patient showed a high transferrin saturation and a high ferritin concentration, (86% and 676&#x000a0;ng/dL, respectively). Moreover, we could not identify any evidence of iron deficiency nor any indicators of iron-deficiency anemia, such as microcytic anemia, following the bleeding event, despite the presence of severe anemia. One possible reason for this absence of iron deficiency was that appropriate iron supplementation was administered following the bleeding event. Therefore, we concluded that not only the iron-deficiency anemia but also the severe anemia, without iron deficiency, may have contributed to the secondary thrombocytosis.</p><p id="Par14">In conclusion, we have reported a rare case of culture-negative PD-associated peritonitis caused by SMA thrombosis with intestinal necrosis. In cases of culture-negative PD-associated peritonitis, enteric peritonitis caused by arterial thrombosis should be considered at an early stage; and in particular, special attention should be paid to patients who experience bleeding episodes, with or without iron deficiency.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank Mark Cleasby, PhD, from Edanz (<ext-link ext-link-type="uri" xlink:href="https://jp.edanz.com/ac">https://jp.edanz.com/ac</ext-link>), for editing a draft of this manuscript.</p></ack><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding provided by Hiroshima University.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par15">The authors have declared that no conflict of interest exists.</p></notes><notes id="FPar2"><title>Research involving human participants</title><p id="Par16">This article does not contain any studies with human participants or animals performed by any of the authors.</p></notes><notes id="FPar3"><title>Informed consent for publication</title><p id="Par17">Informed consent was obtained from individual participants.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000&#x02013;2007)</article-title><source>Perit Dial Int</source><year>2011</year><volume>31</volume><issue>6</issue><fpage>639</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.3747/pdi.2010.00185</pub-id><pub-id pub-id-type="pmid">21804138</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Brown MC, et al. Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000&#x02013;2007). Perit Dial Int. 2011;31(6):639&#x02013;50.<pub-id pub-id-type="pmid">21804138</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>PK</given-names></name><etal/></person-group><article-title>ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment</article-title><source>Perit Dial Int</source><year>2022</year><volume>42</volume><issue>2</issue><fpage>110</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1177/08968608221080586</pub-id><pub-id pub-id-type="pmid">35264029</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Li PK, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110&#x02013;53.<pub-id pub-id-type="pmid">35264029</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>Y</given-names></name><name><surname>Johnson</surname><given-names>DW</given-names></name></person-group><article-title>Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes</article-title><source>Am J Kidney Dis</source><year>2014</year><volume>64</volume><issue>2</issue><fpage>278</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2014.02.025</pub-id><pub-id pub-id-type="pmid">24751170</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis. 2014;64(2):278&#x02013;89.<pub-id pub-id-type="pmid">24751170</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Kanjanabuch</surname><given-names>T</given-names></name><etal/></person-group><article-title>The culture from peritoneal dialysis catheter enhances yield of microorganism identification in peritoneal dialysis-related peritonitis</article-title><source>Perit Dial Int</source><year>2020</year><volume>40</volume><issue>1</issue><fpage>93</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1177/0896860819878387</pub-id><pub-id pub-id-type="pmid">32063145</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Kanjanabuch T, et al. The culture from peritoneal dialysis catheter enhances yield of microorganism identification in peritoneal dialysis-related peritonitis. Perit Dial Int. 2020;40(1):93&#x02013;5.<pub-id pub-id-type="pmid">32063145</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>F</given-names></name><etal/></person-group><article-title>A quarter of a century of adult peritoneal dialysis-related peritonitis at an Australian medical center</article-title><source>Perit Dial Int</source><year>2007</year><volume>27</volume><issue>5</issue><fpage>565</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1177/089686080702700518</pub-id><pub-id pub-id-type="pmid">17704449</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Brown F, et al. A quarter of a century of adult peritoneal dialysis-related peritonitis at an Australian medical center. Perit Dial Int. 2007;27(5):565&#x02013;74.<pub-id pub-id-type="pmid">17704449</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Szeto</surname><given-names>CC</given-names></name><etal/></person-group><article-title>The clinical course of culture-negative peritonitis complicating peritoneal dialysis</article-title><source>Am J Kidney Dis</source><year>2003</year><volume>42</volume><issue>3</issue><fpage>567</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1016/S0272-6386(03)00790-X</pub-id><pub-id pub-id-type="pmid">12955686</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Szeto CC, et al. The clinical course of culture-negative peritonitis complicating peritoneal dialysis. Am J Kidney Dis. 2003;42(3):567&#x02013;74.<pub-id pub-id-type="pmid">12955686</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Fahim</surname><given-names>M</given-names></name><etal/></person-group><article-title>Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases</article-title><source>Am J Kidney Dis</source><year>2010</year><volume>55</volume><issue>4</issue><fpage>690</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2009.11.015</pub-id><pub-id pub-id-type="pmid">20110144</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Fahim M, et al. Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis. 2010;55(4):690&#x02013;7.<pub-id pub-id-type="pmid">20110144</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>de Freitas</surname><given-names>DG</given-names></name><name><surname>Gokal</surname><given-names>R</given-names></name></person-group><article-title>Sterile peritonitis in the peritoneal dialysis patient</article-title><source>Perit Dial Int</source><year>2005</year><volume>25</volume><issue>2</issue><fpage>146</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1177/089686080502500207</pub-id><pub-id pub-id-type="pmid">15796141</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">de Freitas DG, Gokal R. Sterile peritonitis in the peritoneal dialysis patient. Perit Dial Int. 2005;25(2):146&#x02013;51.<pub-id pub-id-type="pmid">15796141</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Ekart</surname><given-names>R</given-names></name><etal/></person-group><article-title>Gangrenous appendicitis presenting as acute abdominal pain in a patient on automated peritoneal dialysis: a case report</article-title><source>J Med Case Rep</source><year>2012</year><volume>6</volume><fpage>309</fpage><pub-id pub-id-type="doi">10.1186/1752-1947-6-309</pub-id><pub-id pub-id-type="pmid">22989294</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Ekart R, et al. Gangrenous appendicitis presenting as acute abdominal pain in a patient on automated peritoneal dialysis: a case report. J Med Case Rep. 2012;6:309.<pub-id pub-id-type="pmid">22989294</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Manga</surname><given-names>F</given-names></name><etal/></person-group><article-title>Acute pancreatitis in peritoneal dialysis: a case report with literature review</article-title><source>Eur J Gastroenterol Hepatol</source><year>2012</year><volume>24</volume><issue>1</issue><fpage>95</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1097/MEG.0b013e32834d4bcc</pub-id><pub-id pub-id-type="pmid">22027700</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Manga F, et al. Acute pancreatitis in peritoneal dialysis: a case report with literature review. Eur J Gastroenterol Hepatol. 2012;24(1):95&#x02013;101.<pub-id pub-id-type="pmid">22027700</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Splenic infarction: an unrecognized cause of culture-negative peritonitis in a continuous ambulatory peritoneal dialysis patient</article-title><source>Clin Nephrol</source><year>2007</year><volume>68</volume><issue>4</issue><fpage>262</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.5414/CNP68262</pub-id><pub-id pub-id-type="pmid">17969497</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Yang CC, et al. Splenic infarction: an unrecognized cause of culture-negative peritonitis in a continuous ambulatory peritoneal dialysis patient. Clin Nephrol. 2007;68(4):262&#x02013;5.<pub-id pub-id-type="pmid">17969497</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Kern</surname><given-names>EO</given-names></name><etal/></person-group><article-title>Abdominal catastrophe revisited: the risk and outcome of enteric peritoneal contamination</article-title><source>Perit Dial Int</source><year>2002</year><volume>22</volume><issue>3</issue><fpage>323</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1177/089686080202200305</pub-id><pub-id pub-id-type="pmid">12227389</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Kern EO, et al. Abdominal catastrophe revisited: the risk and outcome of enteric peritoneal contamination. Perit Dial Int. 2002;22(3):323&#x02013;34.<pub-id pub-id-type="pmid">12227389</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Shrestha</surname><given-names>BM</given-names></name><name><surname>Brown</surname><given-names>P</given-names></name><name><surname>Wilkie</surname><given-names>M</given-names></name></person-group><article-title>Surgical peritonitis in patients on peritoneal dialysis</article-title><source>Perit Dial Int</source><year>2008</year><volume>28</volume><issue>4</issue><fpage>331</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1177/089686080802800403</pub-id><pub-id pub-id-type="pmid">18556371</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Shrestha BM, Brown P, Wilkie M. Surgical peritonitis in patients on peritoneal dialysis. Perit Dial Int. 2008;28(4):331&#x02013;4.<pub-id pub-id-type="pmid">18556371</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Fryc</surname><given-names>J</given-names></name><name><surname>Naumnik</surname><given-names>B</given-names></name></person-group><article-title>Thrombolome and its emerging role in chronic kidney diseases</article-title><source>Toxins (Basel)</source><year>2021</year><volume>13</volume><issue>3</issue><fpage>223</fpage><pub-id pub-id-type="doi">10.3390/toxins13030223</pub-id><pub-id pub-id-type="pmid">33803899</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Fryc J, Naumnik B. Thrombolome and its emerging role in chronic kidney diseases. Toxins (Basel). 2021;13(3):223.<pub-id pub-id-type="pmid">33803899</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Kassahun</surname><given-names>WT</given-names></name><etal/></person-group><article-title>Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review</article-title><source>Langenbecks Arch Surg</source><year>2008</year><volume>393</volume><issue>2</issue><fpage>163</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1007/s00423-007-0263-5</pub-id><pub-id pub-id-type="pmid">18172675</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Kassahun WT, et al. Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review. Langenbecks Arch Surg. 2008;393(2):163&#x02013;71.<pub-id pub-id-type="pmid">18172675</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta-Merida</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Identification of risk factors for perioperative mortality in acute mesenteric ischemia</article-title><source>World J Surg</source><year>2006</year><volume>30</volume><issue>8</issue><fpage>1579</fpage><lpage>1585</lpage><pub-id pub-id-type="doi">10.1007/s00268-005-0560-5</pub-id><pub-id pub-id-type="pmid">16865320</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Acosta-Merida MA, et al. Identification of risk factors for perioperative mortality in acute mesenteric ischemia. World J Surg. 2006;30(8):1579&#x02013;85.<pub-id pub-id-type="pmid">16865320</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Heys</surname><given-names>SD</given-names></name><name><surname>Brittenden</surname><given-names>J</given-names></name><name><surname>Crofts</surname><given-names>TJ</given-names></name></person-group><article-title>Acute mesenteric ischaemia: the continuing difficulty in early diagnosis</article-title><source>Postgrad Med J</source><year>1993</year><volume>69</volume><issue>807</issue><fpage>48</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1136/pgmj.69.807.48</pub-id><pub-id pub-id-type="pmid">8446551</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Heys SD, Brittenden J, Crofts TJ. Acute mesenteric ischaemia: the continuing difficulty in early diagnosis. Postgrad Med J. 1993;69(807):48&#x02013;51.<pub-id pub-id-type="pmid">8446551</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta</surname><given-names>S</given-names></name><etal/></person-group><article-title>Clinical implications for the management of acute thromboembolic occlusion of the superior mesenteric artery: autopsy findings in 213 patients</article-title><source>Ann Surg</source><year>2005</year><volume>241</volume><issue>3</issue><fpage>516</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1097/01.sla.0000154269.52294.57</pub-id><pub-id pub-id-type="pmid">15729076</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Acosta S, et al. Clinical implications for the management of acute thromboembolic occlusion of the superior mesenteric artery: autopsy findings in 213 patients. Ann Surg. 2005;241(3):516&#x02013;22.<pub-id pub-id-type="pmid">15729076</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Papen</surname><given-names>M</given-names></name><name><surname>Ghijselings</surname><given-names>S</given-names></name><name><surname>Vles</surname><given-names>G</given-names></name></person-group><article-title>Reactive thrombocytosis leading to recurrent arterial thrombosis reversed by management of a prosthetic joint infection of the hip</article-title><source>Cureus</source><year>2022</year><volume>14</volume><issue>4</issue><fpage>e24166</fpage><pub-id pub-id-type="pmid">35449801</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Papen M, Ghijselings S, Vles G. Reactive thrombocytosis leading to recurrent arterial thrombosis reversed by management of a prosthetic joint infection of the hip. Cureus. 2022;14(4): e24166.<pub-id pub-id-type="pmid">35449801</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Paraneoplastic thrombocytosis in ovarian cancer</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><issue>7</issue><fpage>610</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1110352</pub-id><pub-id pub-id-type="pmid">22335738</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Stone RL, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366(7):610&#x02013;8.<pub-id pub-id-type="pmid">22335738</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Recurrent arterial thrombosis of the lower extremity with secondary thrombocythemia due to reperfusion injury: a case report</article-title><source>Ann Palliat Med</source><year>2020</year><volume>9</volume><issue>5</issue><fpage>3690</fpage><lpage>3697</lpage><pub-id pub-id-type="doi">10.21037/apm-20-1649</pub-id><pub-id pub-id-type="pmid">33065806</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Geng Y, et al. Recurrent arterial thrombosis of the lower extremity with secondary thrombocythemia due to reperfusion injury: a case report. Ann Palliat Med. 2020;9(5):3690&#x02013;7.<pub-id pub-id-type="pmid">33065806</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Raso</surname><given-names>S</given-names></name><etal/></person-group><article-title>Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia</article-title><source>Ann Hematol</source><year>2016</year><volume>95</volume><issue>8</issue><fpage>1389</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1007/s00277-016-2715-x</pub-id><pub-id pub-id-type="pmid">27256347</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Raso S, et al. Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia. Ann Hematol. 2016;95(8):1389&#x02013;90.<pub-id pub-id-type="pmid">27256347</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Basak</surname><given-names>R</given-names></name><etal/></person-group><article-title>Stroke in the young: relationship with iron deficiency anemia and thrombocytosis</article-title><source>Mymensingh Med J</source><year>2008</year><volume>17</volume><issue>1</issue><fpage>74</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">18285738</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Basak R, et al. Stroke in the young: relationship with iron deficiency anemia and thrombocytosis. Mymensingh Med J. 2008;17(1):74&#x02013;7.<pub-id pub-id-type="pmid">18285738</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Buss</surname><given-names>DH</given-names></name><etal/></person-group><article-title>Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases</article-title><source>Am J Med</source><year>1994</year><volume>96</volume><issue>3</issue><fpage>247</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/0002-9343(94)90150-3</pub-id><pub-id pub-id-type="pmid">8154513</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Buss DH, et al. Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med. 1994;96(3):247&#x02013;53.<pub-id pub-id-type="pmid">8154513</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Bunke</surname><given-names>M</given-names></name><name><surname>Brier</surname><given-names>ME</given-names></name><name><surname>Golper</surname><given-names>TA</given-names></name></person-group><article-title>Culture-negative CAPD peritonitis: the network 9 study</article-title><source>Adv Perit Dial</source><year>1994</year><volume>10</volume><fpage>174</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">7999821</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Bunke M, Brier ME, Golper TA. Culture-negative CAPD peritonitis: the network 9 study. Adv Perit Dial. 1994;10:174&#x02013;8.<pub-id pub-id-type="pmid">7999821</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Htay</surname><given-names>H</given-names></name><etal/></person-group><article-title>Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients</article-title><source>Perit Dial Int</source><year>2020</year><volume>40</volume><issue>1</issue><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1177/0896860819879891</pub-id><pub-id pub-id-type="pmid">32063153</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Htay H, et al. Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients. Perit Dial Int. 2020;40(1):47&#x02013;56.<pub-id pub-id-type="pmid">32063153</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>DW</given-names></name><name><surname>Gray</surname><given-names>N</given-names></name><name><surname>Snelling</surname><given-names>P</given-names></name></person-group><article-title>A peritoneal dialysis patient with fatal culture-negative peritonitis</article-title><source>Nephrology (Carlton)</source><year>2003</year><volume>8</volume><issue>1</issue><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1046/j.1440-1797.2003.00119.x</pub-id><pub-id pub-id-type="pmid">15012750</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Johnson DW, Gray N, Snelling P. A peritoneal dialysis patient with fatal culture-negative peritonitis. Nephrology (Carlton). 2003;8(1):49&#x02013;55.<pub-id pub-id-type="pmid">15012750</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Nochaiwong</surname><given-names>S</given-names></name><etal/></person-group><article-title>A clinical risk prediction tool for peritonitis-associated treatment failure in peritoneal dialysis patients</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><issue>1</issue><fpage>14797</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-33196-2</pub-id><pub-id pub-id-type="pmid">30287920</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Nochaiwong S, et al. A clinical risk prediction tool for peritonitis-associated treatment failure in peritoneal dialysis patients. Sci Rep. 2018;8(1):14797.<pub-id pub-id-type="pmid">30287920</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis</article-title><source>Clin J Am Soc Nephrol</source><year>2006</year><volume>1</volume><issue>4</issue><fpage>768</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.2215/CJN.01010306</pub-id><pub-id pub-id-type="pmid">17699285</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Chow KM, et al. Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis. Clin J Am Soc Nephrol. 2006;1(4):768&#x02013;73.<pub-id pub-id-type="pmid">17699285</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Qingyan</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Peritoneal dialysis related eosinophilic peritonitis: a case report and review of the literature</article-title><source>BMC Nephrol</source><year>2023</year><volume>24</volume><issue>1</issue><fpage>10</fpage><pub-id pub-id-type="doi">10.1186/s12882-022-03027-8</pub-id><pub-id pub-id-type="pmid">36635670</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Qingyan Z, et al. Peritoneal dialysis related eosinophilic peritonitis: a case report and review of the literature. BMC Nephrol. 2023;24(1):10.<pub-id pub-id-type="pmid">36635670</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Burkart</surname><given-names>J</given-names></name><etal/></person-group><article-title>Usefulness of peritoneal fluid amylase levels in the differential diagnosis of peritonitis in peritoneal dialysis patients</article-title><source>J Am Soc Nephrol</source><year>1991</year><volume>1</volume><issue>10</issue><fpage>1186</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1681/ASN.V1101186</pub-id><pub-id pub-id-type="pmid">1722717</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Burkart J, et al. Usefulness of peritoneal fluid amylase levels in the differential diagnosis of peritonitis in peritoneal dialysis patients. J Am Soc Nephrol. 1991;1(10):1186&#x02013;90.<pub-id pub-id-type="pmid">1722717</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Mesenteric ischemia: what the radiologist needs to know</article-title><source>Cardiovasc Diagn Ther</source><year>2019</year><volume>9</volume><issue>Suppl 1</issue><fpage>S74</fpage><lpage>S87</lpage><pub-id pub-id-type="doi">10.21037/cdt.2018.09.06</pub-id><pub-id pub-id-type="pmid">31559155</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Olson MC, et al. Mesenteric ischemia: what the radiologist needs to know. Cardiovasc Diagn Ther. 2019;9(Suppl 1):S74&#x02013;87.<pub-id pub-id-type="pmid">31559155</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Vannucchi</surname><given-names>AM</given-names></name><name><surname>Barbui</surname><given-names>T</given-names></name></person-group><article-title>Thrombocytosis and thrombosis</article-title><source>Hematol Am Soc Hematol Educ Progr</source><year>2007</year><volume>1</volume><fpage>363</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1182/asheducation-2007.1.363</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Vannucchi AM, Barbui T. Thrombocytosis and thrombosis. Hematol Am Soc Hematol Educ Progr. 2007;1:363&#x02013;70.</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>K</given-names></name><etal/></person-group><article-title>Secondary thrombocythemia with ST-segment elevation myocardial infarction as the first manifestation: a case report</article-title><source>Ann Med Surg (Lond)</source><year>2023</year><volume>85</volume><issue>8</issue><fpage>4145</fpage><lpage>4149</lpage><pub-id pub-id-type="doi">10.1097/MS9.0000000000001067</pub-id><pub-id pub-id-type="pmid">37554887</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Su K, et al. Secondary thrombocythemia with ST-segment elevation myocardial infarction as the first manifestation: a case report. Ann Med Surg (Lond). 2023;85(8):4145&#x02013;9.<pub-id pub-id-type="pmid">37554887</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Edahiro</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Causes of thrombocytosis: a single-center retrospective study of 1202 patients</article-title><source>Intern Med</source><year>2022</year><volume>61</volume><issue>22</issue><fpage>3323</fpage><lpage>3328</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.9282-21</pub-id><pub-id pub-id-type="pmid">36385045</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Edahiro Y, et al. Causes of thrombocytosis: a single-center retrospective study of 1202 patients. Intern Med. 2022;61(22):3323&#x02013;8.<pub-id pub-id-type="pmid">36385045</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>AB</given-names></name><name><surname>Kuter</surname><given-names>DJ</given-names></name><name><surname>Al-Samkari</surname><given-names>H</given-names></name></person-group><article-title>Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia</article-title><source>Am J Hematol</source><year>2020</year><volume>10</volume><fpage>1180</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.1002/ajh.25925</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Song AB, Kuter DJ, Al-Samkari H. Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia. Am J Hematol. 2020;10:1180&#x02013;6.</mixed-citation></citation-alternatives></ref></ref-list></back></article>